Precigen Inc
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of … Read more
Precigen Inc (PGEN) - Total Assets
Latest total assets as of September 2025: $171.26 Million USD
Based on the latest financial reports, Precigen Inc (PGEN) holds total assets worth $171.26 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Precigen Inc - Total Assets Trend (2011–2024)
This chart illustrates how Precigen Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Precigen Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Precigen Inc's total assets of $171.26 Million consist of 70.5% current assets and 29.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.3% |
| Accounts Receivable | $1.16 Million | 0.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.46 Million | 3.1% |
| Goodwill | $19.14 Million | 13.2% |
Asset Composition Trend (2011–2024)
This chart illustrates how Precigen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Precigen Inc's current assets represent 70.5% of total assets in 2024, an increase from 20.0% in 2011.
- Cash Position: Cash and equivalents constituted 20.3% of total assets in 2024, up from 17.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, a decrease from 28.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 13.2% of total assets.
Precigen Inc Competitors by Total Assets
Key competitors of Precigen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Precigen Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Precigen Inc generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Precigen Inc is currently not profitable relative to its asset base.
Precigen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.04 | 1.63 | 3.54 |
| Quick Ratio | 3.95 | 1.63 | 3.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $97.53 Million | $ 13.30 Million | $ 106.82 Million |
Precigen Inc - Advanced Valuation Insights
This section examines the relationship between Precigen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 28.14 |
| Latest Market Cap to Assets Ratio | 2.99 |
| Asset Growth Rate (YoY) | -3.8% |
| Total Assets | $145.27 Million |
| Market Capitalization | $434.08 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Precigen Inc's assets at a significant premium ( 2.99x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Precigen Inc's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Precigen Inc (2011–2024)
The table below shows the annual total assets of Precigen Inc from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $145.27 Million | -3.82% |
| 2023-12-31 | $151.04 Million | -30.07% |
| 2022-12-31 | $215.98 Million | -39.98% |
| 2021-12-31 | $359.86 Million | +14.39% |
| 2020-12-31 | $314.59 Million | -30.98% |
| 2019-12-31 | $455.76 Million | -36.36% |
| 2018-12-31 | $716.18 Million | -15.43% |
| 2017-12-31 | $846.85 Million | -10.77% |
| 2016-12-31 | $949.07 Million | -3.36% |
| 2015-12-31 | $982.05 Million | +70.41% |
| 2014-12-31 | $576.27 Million | +22.75% |
| 2013-12-31 | $469.47 Million | +209.58% |
| 2012-12-31 | $151.65 Million | +32.06% |
| 2011-12-31 | $114.83 Million | -- |